Study finds melanoma biomarkers predicting checkpoint blocker response
Scientists at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) have identified biomarkers in melanoma that could help tailor immunotherapy treatments to […]
» Read more